4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-042290
Chief Operating Officer sold 14,583 shares at $40.00 ($583,320)
- Chief Operating Officer acquired 14,583 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ADAMS R MARK Chief Operating Officer | 2021-06-17 | Option exercise | +14,583 | $28.10 | $409,782 | 72,687 | D: show line 1 in the form |
| ADAMS R MARK Chief Operating Officer | 2021-06-17 | Sale | −14,583 | $40.00 | $583,320 | 58,104 | D: show line 2 in the form |
| Open-market sales · 14,583 sh · avg $40.00 · $583,320 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| ADAMS R MARK Chief Operating Officer | 2021-06-17 | Option exercise · Stock Option (Right to Buy) | −14,583 | 35,417 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…